Company page

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. (ticker: ARWR) is a public company based in the United States with a market capitalization of approximately $11.5 billion. The company focuses on developing innovative therapies to treat various diseases using its proprietary RNA-targeted technology. Arrowhead is committed to advancing its pipeline of drug candidates to address unmet medical needs in the pharmaceutical market.